Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>HENGRUI PHARMA Sees 21.78% YoY Growth in 1Q NP Attributable to Shareholders
Recommend 12 Positive 13 Negative 4 |
||||
|
||||
|
HENGRUI PHARMA (01276.HK) announced that its operating revenue for 1Q26 rose by 12.98% YoY to RMB8.141 billion, while net profit attributable to its shareholders increased by 21.78% YoY to RMB2.282 billion, with basic EPS of RMB0.34. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
